Lisi Group Secures 99.66% Shareholder Support for All 12 AGM Resolutions, Renews Board and Obtains Fresh Capital Mandates

Bulletin Express
08/28

Lisi Group (Holdings) Limited reported near-unanimous backing for every agenda item at its Annual General Meeting held on 28 August 2026. All 12 ordinary resolutions garnered 99.66% of the 3.19 billion votes cast, with only 10.90 million votes (0.34%) recorded against each motion.

Key approvals:

1. FY 2026 financial statements: Shareholders adopted the audited consolidated results for the year ended 31 March 2026.

2. Board composition: Executive directors Mr Xu Jinbo, Mr Wang Yong and Mr Wang Bo, together with independent non-executive directors Ms Chen Wei, Mr Jiang Yuexiang and Ms Ke Yue, were all re-elected.

3. Remuneration: The board was authorised to determine directors’ remuneration.

4. Auditor mandate: Forvis Mazars CPA Limited was re-appointed as external auditor, with remuneration to be set by the board.

5. Capital authorities: • A fresh mandate allows directors to issue and deal with shares up to 20% of the company’s existing issued share capital. • A separate mandate permits the repurchase of up to 10% of issued shares. • The share-issue mandate can be extended by the number of shares bought back under the repurchase authority.

Operational details:

• Total shares in issue and entitled to vote: 8.84 billion. • No shareholder was required to abstain or limited to voting against any resolution. • Tricor Investor Services Limited acted as scrutineer for the poll. • Executive and independent non-executive directors participated in the meeting, with Ms Chen Wei attending in person and the remaining directors joining electronically.

The decisive outcomes reinforce shareholder confidence in Lisi Group’s current leadership and provide the board with expanded flexibility for capital management in the coming year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10